{
    "nctId": "NCT02701348",
    "briefTitle": "Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers",
    "officialTitle": "Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 31,
    "primaryOutcomeMeasure": "Change in Proliferative response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women: Defined as \\>12 months amenorrhoea in absence of medical therapy known to induce this; or bilateral oophorectomy; or if last menses \\<12 months before starting treatment, FSH \\>35 IU/L and LH \\>40 IU/L.\n* ER positive (Allred score \\>3) invasive breast cancer\n* Staging as T1-4, N0-2, M0\n* Patient agreed to neoadjuvant endocrine therapy as recommended by MDT\n* Fresh tissue stored at time of diagnostic core biopsy\n* Suitable for, and tolerant of MRI scan\n* Fit for surgical intervention at time of entry into study\n\nExclusion Criteria:\n\n* Premenopausal or unable to determine menopausal status\n* Not fit for surgical intervention due to co-morbidities\n* Contraindication for MRI (including severe claustrophobia)\n* Current use of HRT, or HRT use at time of diagnostic core biopsy",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}